Javier Valero-Elizondo, MD, MPH
Javier Valero-Elizondo, MD, MPH
Dirección de correo verificada de houstonmethodist.org
Título
Citado por
Citado por
Año
National trends in statin use and expenditures in the US adult population from 2002 to 2013: insights from the Medical Expenditure Panel Survey
JA Salami, H Warraich, J Valero-Elizondo, ES Spatz, NR Desai, JS Rana, ...
JAMA cardiology 2 (1), 56-65, 2017
2132017
Association of subjective and objective sleep duration as well as sleep quality with non-invasive markers of sub-clinical cardiovascular disease (CVD): a systematic review
M Aziz, SS Ali, S Das, A Younus, R Malik, MA Latif, C Humayun, ...
Journal of atherosclerosis and thrombosis 24 (3), 208-226, 2017
702017
Association of out-of-pocket annual health expenditures with financial hardship in low-income adults with atherosclerotic cardiovascular disease in the United States
R Khera, J Valero-Elizondo, V Okunrintemi, A Saxena, SR Das, ...
JAMA cardiology 3 (8), 729-738, 2018
442018
Patient–provider communication and health outcomes among individuals with atherosclerotic cardiovascular disease in the United States: medical expenditure panel survey 2010 to 2013
V Okunrintemi, ES Spatz, P Di Capua, JA Salami, J Valero-Elizondo, ...
Circulation: Cardiovascular Quality and Outcomes 10 (4), e003635, 2017
392017
Favorable cardiovascular risk profile is associated with lower healthcare costs and resource utilization: the 2012 Medical Expenditure Panel Survey
J Valero-Elizondo, JA Salami, O Ogunmoroti, CU Osondu, EC Aneni, ...
Circulation: Cardiovascular Quality and Outcomes 9 (2), 143-153, 2016
332016
Gender differences in patient‐reported outcomes among adults with atherosclerotic cardiovascular disease
V Okunrintemi, J Valero‐Elizondo, B Patrick, J Salami, M Tibuakuu, ...
Journal of the American Heart Association 7 (24), e010498, 2018
302018
Economic impact of Moderate‐Vigorous physical activity among those with and without established cardiovascular disease: 2012 medical expenditure Panel Survey
J Valero‐Elizondo, JA Salami, CU Osondu, O Ogunmoroti, A Arrieta, ...
Journal of the American Heart Association 5 (9), e003614, 2016
282016
Cost-related medication nonadherence in adults with atherosclerotic cardiovascular disease in the United States, 2013 to 2017
R Khera, J Valero-Elizondo, SR Das, SS Virani, BA Kash, JA De Lemos, ...
Circulation 140 (25), 2067-2075, 2019
272019
Estimates of mortality benefit from ideal cardiovascular health metrics: a dose response meta‐analysis
EC Aneni, A Crippa, CU Osondu, J Valero‐Elizondo, A Younus, K Nasir, ...
Journal of the American Heart Association 6 (12), e006904, 2017
262017
Financial hardship from medical bills among nonelderly US adults with atherosclerotic cardiovascular disease
J Valero-Elizondo, R Khera, A Saxena, GR Grandhi, SS Virani, J Butler, ...
Journal of the American College of Cardiology 73 (6), 727-732, 2019
232019
Favorable cardiovascular health is associated with lower health care expenditures and resource utilization in a large us employee population: the baptist health south florida …
CU Osondu, EC Aneni, J Valero-Elizondo, JA Salami, M Rouseff, S Das, ...
Mayo Clinic Proceedings 92 (4), 512-524, 2017
202017
National trends in nonstatin use and expenditures among the US adult population from 2002 to 2013: insights from medical expenditure panel survey
JA Salami, HJ Warraich, J Valero‐Elizondo, ES Spatz, NR Desai, ...
Journal of the American Heart Association 7 (2), e007132, 2018
192018
Persistent socioeconomic disparities in cardiovascular risk factors and health in the United States: Medical Expenditure Panel Survey 2002–2013
J Valero-Elizondo, JC Hong, ES Spatz, JA Salami, NR Desai, JS Rana, ...
Atherosclerosis 269, 301-305, 2018
182018
Trends in use and expenditures of brand-name atorvastatin after introduction of generic atorvastatin
HJ Warraich, JA Salami, R Khera, J Valero-Elizondo, V Okunrintemi, ...
JAMA internal medicine 178 (5), 719-721, 2018
172018
Trends and costs associated with suboptimal physical activity among US women with cardiovascular disease
V Okunrintemi, EMA Benson, M Tibuakuu, D Zhao, O Ogunmoroti, ...
JAMA network open 2 (4), e191977-e191977, 2019
152019
Variation in the use of warfarin and direct oral anticoagulants in atrial fibrillation and associated cost implications
BA Rodwin, JA Salami, ES Spatz, J Valero-Elizondo, SS Virani, ...
The American journal of medicine 132 (1), 61-70. e1, 2019
122019
Temporal trends in e-cigarette use among US adults: Behavioral Risk Factor Surveillance System, 2016 to 2018
M Al Rifai, AT Merchant, V Nambi, X Jia, M Gulati, J Valero-Elizondo, ...
The American journal of medicine 133 (9), e508-e511, 2020
112020
Burden and consequences of financial hardship from medical bills among nonelderly adults with diabetes mellitus in the United States
C Caraballo, J Valero-Elizondo, R Khera, S Mahajan, GR Grandhi, ...
Circulation: Cardiovascular Quality and Outcomes 13 (2), e006139, 2020
112020
Association between financial burden, quality of life, and mental health among those with atherosclerotic cardiovascular disease in the United States
A Annapureddy, J Valero-Elizondo, R Khera, GR Grandhi, ES Spatz, ...
Circulation: Cardiovascular Quality and Outcomes 11 (11), e005180, 2018
112018
Association between modifiable risk factors and pharmaceutical expenditures among adults with atherosclerotic cardiovascular disease in the United States: 2012–2013 medical …
JA Salami, J Valero‐Elizondo, O Ogunmoroti, ES Spatz, JS Rana, ...
Journal of the American Heart Association 6 (6), e004996, 2017
112017
El sistema no puede realizar la operación en estos momentos. Inténtalo de nuevo más tarde.
Artículos 1–20